The NAT2 pharmacogenomic profile of patients from these regions was compared with the reports from several geographically diverse TB populations and participants of different genetic ancestries extracted from literature reviews and the ‘All of Us’ Research Program database, respectively. Here, NAT2 is linked to tuberculosis.